Savonix
Savonix is a San Francisco-based digital health company, founded in 2015, that delivers a clinical, evidence-based, all-mobile digital assessment of cognitive and emotional function, serving clinicians, health systems, payers, and pharmaceutical researchers as potential customers in the neuropsychological assessment market.
- Company typePrivate
- Founded2015
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Savonix does
Savonix is a San Francisco-based digital health company founded in 2015 that operates in the cognitive and behavioral assessment segment. Per its own positioning, it offers what it describes as the world's first clinical, evidence-based, all-mobile digital assessment of cognitive and emotional function, targeting use cases where traditional neuropsychological testing has been the standard. The company has built a small organization (11–50 employees) led by a clinically-credentialed team, including a PhD founder/former CEO, a PhD Chairman, a Chief Science Officer with a DPhil, and a CTO.
The product architecture centers on delivering cognitive and emotional assessments through a mobile interface, replacing or supplementing paper-based or clinician-administered neuropsychological batteries. Savonix's clinical positioning is reinforced by the scientific leadership composition and a roster of healthcare-focused investors (notably DigiTx Partners, a digital health specialist), suggesting the company targets regulated healthcare buyers — clinicians, health systems, payers, and potentially pharmaceutical sponsors running cognitive endpoint studies. Total disclosed funding across seed, Series A, and Series B rounds from 2015 through April 2019 is approximately $16.2 million.
The company's revenue model and pricing structure are not disclosed in the available source data. There is no published pricing model, no named customer logos, and no disclosed ARR or revenue figure. The company's primary public website currently displays only a loader/verification page, providing no further business-model detail. Combined with a headcount band of 11–50 and the last recorded capital event in April 2019, this suggests a small commercial-stage organization whose monetization mechanics — whether enterprise SaaS licensing, per-assessment fees, pharma trial contracts, or payer partnerships — cannot be determined from the input.
Savonix firmographics
Firmographics- Name
- Savonix
- Website
- https://savonix.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Savonix is a San Francisco-based digital health company, founded in 2015, that delivers a clinical, evidence-based, all-mobile digital assessment of cognitive and emotional function, serving clinicians, health systems, payers, and pharmaceutical researchers as potential customers in the neuropsychological assessment market.
- Ownership category
- akta.pro rank
Savonix industry classification
Industry- Product category
- Digital Cognitive Assessment
- NAICS
- Other Computer Related Services (541519), Custom Computer Programming Services (541511)
- SIC
- Services-Prepackaged Software (7372), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
Keywords
Where Savonix is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
Savonix business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Savonix product offering
Product offeringCore offering
Savonix provides an all-mobile, digital assessment platform that clinically and evidence-based evaluates cognitive and emotional function. The product is designed for use by clinicians, researchers, and healthcare organizations to measure neurocognitive performance via mobile devices, eliminating the need for specialized in-clinic testing equipment.
Differentiator
Problem solved
Functional benefit
Products and services
- Savonix Cognitive Assessment Platform
Companies that use Savonix
Customer profileIdeal customer profiles1 record
Savonix technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Savonix partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
Savonix competitors and assessment
Company assessmentDirect peers
- Linus Health: Linus Health offers a digital cognitive assessment platform combining iPad-based testing with AI for early detection of dementia and other neurological conditions. It is a direct peer to Savonix in evidence-based digital cognitive assessment for clinical and research use.
- Neurotrack: Neurotrack develops digital cognitive health tools for screening and monitoring memory and cognitive decline. It overlaps directly with Savonix in mobile cognitive assessment aimed at early detection and longitudinal monitoring.
- Cogstate: Cogstate provides computerized cognitive assessment tools used in clinical trials, healthcare, and research. It is the most direct competitor to Savonix, offering validated digital cognitive testing across similar end markets including pharma-sponsored trials and clinical care.
- ImPACT Applications: ImPACT Applications offers computerized cognitive testing tools widely used in concussion management and clinical research. It is a direct peer in computerized neurocognitive assessment with overlapping use cases in clinical and sports-medicine settings.
- Altoida: Altoida provides a digital cognitive assessment platform using augmented reality and AI on smartphones and tablets for early detection of cognitive impairment. It is a direct peer pursuing the same mobile-first, evidence-based cognitive assessment positioning as Savonix.
- CNS Vital Signs: CNS Vital Signs provides a computerized neurocognitive assessment battery used by clinicians and researchers. It is a direct peer to Savonix in clinical-grade computerized cognitive testing for healthcare and research customers.
- Cambridge Cognition: Cambridge Cognition develops digital cognitive assessments for clinical research and healthcare. It is a direct peer to Savonix, serving pharma, academic, and clinical customers with validated computerized neurocognitive tests.
- BrainCheck: BrainCheck offers a digital cognitive assessment and brain health platform for clinicians and health systems. It competes directly with Savonix in mobile/tablet-based cognitive screening deployed in primary care and specialty neurology.
Emerging players
- Akili Interactive: Akili Interactive develops FDA-cleared digital therapeutics for cognitive dysfunction, including ADHD and multiple sclerosis. It is an emerging peer adjacent to Savonix, focused on prescription digital therapeutics rather than assessment, but operating in the same cognitive-health category.
Broad incumbents
- Pear Therapeutics: Pear Therapeutics was a pioneer in prescription digital therapeutics (PDT) across multiple therapeutic areas including CNS. It is a broad incumbent reference point for the digital therapeutics/SaMD category in which Savonix operates, illustrating both the opportunity and the commercial challenges of evidence-based digital therapeutics.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights4 records
Customer concentration
Savonix social profiles
Digital presenceSavonix financial estimates
Financial estimateRevenue estimate
Valuation estimate
Savonix leadership team
Management profileNumber of profiles
Profiles6 records
Savonix funding detail
Funding detailFunding overview
Funding rounds4 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Savonix M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Savonix
What does Savonix do?
Savonix provides an all-mobile, digital assessment platform that clinically and evidence-based evaluates cognitive and emotional function. The product is designed for use by clinicians, researchers, and healthcare organizations to measure neurocognitive performance via mobile devices, eliminating the need for specialized in-clinic testing equipment.
When was Savonix founded?
Savonix was founded in 2015. It employs 11 to 50 people.
Where is Savonix based?
Savonix is headquartered in San Francisco, United States, in the North America region.
Who are Savonix's main competitors?
Direct peers on record are Linus Health, Neurotrack, Cogstate, ImPACT Applications, Altoida, CNS Vital Signs, Cambridge Cognition and BrainCheck. Akili Interactive is listed as an emerging player. Pear Therapeutics is listed as a broad incumbent.
Does Savonix have an API?
No public API is recorded for Savonix.
What industry is Savonix in?
Savonix's product category is Digital Cognitive Assessment. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital). Its NAICS code is 541519 and its SIC code is 7372.